Per Kogner

Research interests

Publications

• Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin

  Nature Genetics · 2021 · https://doi.org/10.1038/s41588-021-00818-x

• Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

  The Lancet Oncology · 2017 · https://doi.org/10.1016/s1470-2045(17)30070-0

• Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma

  Clinical Cancer Research · 2016 · https://doi.org/10.1158/1078-0432.ccr-15-1912

• Emergence of New ALK Mutations at Relapse of Neuroblastoma

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.54.0674

• The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation

  Cancer Cell · 2014 · https://doi.org/10.1016/j.ccell.2014.09.014

• Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

  Clinical Cancer Research · 2010 · https://doi.org/10.1158/1078-0432.ccr-09-2660

• High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset

  Proceedings of the National Academy of Sciences · 2010 · https://doi.org/10.1073/pnas.0910684107

• High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours

  Biochemical Journal · 2008 · https://doi.org/10.1042/bj20081834

• FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.

  Proceedings of the National Academy of Sciences · 1995 · https://doi.org/10.1073/pnas.92.1.195

Current projects

No projects listed.